A case of combination treatment of femoral osteosarcoma
Authors:
- A. A. FilimonovAFA. A. Filimonov
- N. M. KutakovNKN. M. Kutakov
- E. M. MusaevEME. M. Musaev
- A. G. ZhukovAZA. G. Zhukov
- O. L. TimofeevaOTO. L. Timofeeva
- F. M. AbbasbeyliFAF. M. Abbasbeyli
- Yu. E. RyabukhinaYRYu. E. Ryabukhina
- P. A. ZeynalovaPZP. A. Zeynalova
- A. A. FedenkoAFA. A. Fedenko
- E. K. IbragimovEIE. K. Ibragimov
Open Access
- 14 December 2022
- journal article
- research article
- Published by Publishing House ABV Press in MD-Onco
- Vol. 2 (4) , 56-62
Abstract
Osteosarcomas are rare tumors with aggressive biology. It is important to refer such patients to a high-volume center, where an accurate diagnosis and optimal treatment are more likely to be performed. In contrast to Ewing's sarcoma, conventional osteosarcomas are believed to be generally resistant to radiation therapy, and the main treatment modalities are surgery and chemotherapy. In this clinical case, we demonstrate the efficacy of combined treatment of osteosarcoma of the femur.Preoperative chemotherapy allowed to evaluate tumor sensitivity to systemic treatment in vivo and optimize adjuvant treatment after R0 resection which allowed to achieve complete clinical response to treatment.Keywords
This publication has 27 references indexed in Scilit:
- Long‐term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high‐grade, operable osteosarcomaCancer, 2012
- Osteosarcoma incidence and survival rates from 1973 to 2004Cancer, 2009
- Perinatal factors, growth and development, and osteosarcoma riskBritish Journal of Cancer, 2006
- Neoadjuvant chemotherapy for high‐grade central osteosarcoma of the extremityCancer, 2003
- Presurgical Chemotherapy Compared With Immediate Surgery and Adjuvant Chemotherapy for Nonmetastatic Osteosarcoma: Pediatric Oncology Group Study POG-8651Journal of Clinical Oncology, 2003
- Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma IntergroupEuropean Journal of Cancer, 2002
- Etiology of OsteosarcomaClinical Orthopaedics and Related Research, 2002
- Adjuvant Chemotherapy of High-Grade Osteosarcoma of the ExtremityClinical Orthopaedics and Related Research, 1991
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- Primary osteogenic sarcoma: Eight-year experience with adjuvant chemotherapyJournal of Cancer Research and Clinical Oncology, 1983